FY 2013 Contract HHSN271201300012C, SBIR-1, Topic 003, Automated Instrument for C
FY 2013 Contract HHSN271201300012C, SBIR-1, Topic 003, Automated Instrument for C
批准号:
8756438
负责人:
JIMMY LU
金额:
$15.85万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-10 至 2014-03-09
关键词:
Applications GrantsBiological AssayCellsChemicalsContractsCytoplasmDyesEngineeringFluorescenceMatrix MetalloproteinasesMeasuresMembrane PotentialsMitochondriaParentsPhasePropertySmall Business Innovation Research GrantSolubilityTimeToxic effectWorkbasecosthazardhigh throughput screeninginstrumentmitochondrial membranemonomernovelwater solubility
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In this SBIR phase I grant application, Codex BioSolutions proposes to construct a cell-based high throughput assay that measures chemical toxicity using a novel dye, m-MPI. This dye was engineered to overcome many
of the drawbacks of current dyes used to measure mitochondrial membrane potential. The parent dye JC-1 has been used for this purpose previously. In the mitochondria, where it accumulates as aggregates, it fluoresces red, whereas in the cytoplasm where it is a monomer, it fluoresces green. However, JC-1 is difficult to use because it has very low water solubility which makes using its differential fluorescent properties difficult. Our dye, m-MPI has increased solubility allowing easy quantitative assessment of MMP status simply by calculating the ratio of red/green fluorescence. m-MPI can also be used with cells that do not work with JC-1 (such as primary cells) due at least in part to its increased sensitivity. We believe our assay will more accurately assess hazards in a shorter time and with less cost.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DEVELOPMENT OF NOVEL PDE4B INHIBITORS TO TREAT ALCOHOL USE DISORDER (SBIR PHASE II)
-
批准号:10037802
-
项目类别:
-
资助金额:$99.88万
-
财政年份:2019
-
负责人:JIMMY LU
-
依托单位:
IGF::OT::IGF "Development of Novel PDE4B Inhibitors to Treat Alcohol Use Disorder" (SBIR Phase I)
-
批准号:9581310
-
项目类别:
-
资助金额:$22.47万
-
财政年份:2017
-
负责人:JIMMY LU
-
依托单位:
海外基金